www.g4media.ro/pastila-considerata-cel-mai-importa
A new pill, darakonrasib, shows promise in treating advanced pancreatic cancer, with some patients experiencing tumor shrinkage or disappearance. In a clinical trial, cancer became undetectable in one out of twelve patients, and tumors stopped growing in nearly all participants. While not a cure, the results suggest improved survival rates compared to traditional chemotherapy. The drug targets KRAS mutations common in pancreatic cancer, raising hopes for its effectiveness against other cancers as well. Further studies are needed to assess long-term effects and potential NHS approval.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.